| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $59.0M | — | -33.1% |
| Cost of Revenue | $17.4M | — | +4.9% |
| Gross Profit | $41.6M | — | -41.9% |
| R&D Expense | $4.1M | — | +24.4% |
| SG&A Expense | $53.2M | — | -11.2% |
| Operating Income | -$16.0M | — | -294.5% |
| Pre-tax Income | -$15.3M | — | -278.0% |
| Income Tax | -$4.5M | — | -381.4% |
| Net Income | -$10.9M | — | -254.6% |
| EPS (Basic) | -$0.07 | — | -240.0% |
| EPS (Diluted) | -$0.07 | — | -240.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $159.8M | -3.8% | +50.1% |
| Accounts Receivable | $46.0M | -39.2% | -26.1% |
| Inventory | $26.2M | +3.5% | +9.0% |
| Current Assets | $240.3M | -13.4% | +20.1% |
| Total Assets | $308.7M | -9.9% | +14.1% |
| Current Liabilities | $44.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.9M | — | -64.5% |
| Investing Cash Flow | -$5.6M | — | -1289.7% |
| Financing Cash Flow | -$2.6M | — | +10.2% |
| +4.5% |
| Long-term Debt | $16.1M | -10.6% | -8.2% |
| Total Liabilities | $65.7M | -23.7% | -2.8% |
| Stockholders' Equity | $242.9M | -5.3% | +19.8% |